Latest Lead News

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

CurveBeam AI has broadened its commercial agreement with Stryker to cover Australia and New Zealand, aiming to accelerate adoption of its HiRise weight bearing CT scanners through targeted surgeon education and promotion.

Canyon Resources has locked in a $124 million underwriting agreement with major shareholder Eagle Eye Asset Holdings to finance critical rolling stock for its Minim Martap bauxite project in Cameroon, marking a pivotal step towards production.

Atturra Limited has acknowledged ongoing preliminary discussions to acquire US-based Kitepipe, a Platinum Boomi Partner, amid market speculation. While talks are incomplete, this move aligns with Atturra’s active M&A strategy.

EMVision Medical Devices reports strong progress in clinical trials for its emu™ Bedside Scanner, backed by robust cash reserves and strategic non-dilutive funding. The company is poised to commence pivotal FDA validation trials, marking a key step toward commercialisation.

Terramin's December 2024 quarterly report reveals major progress at its Tala Hamza Zinc Project with land acquisition and a $336 million EPC contract, while the Bird in Hand Gold Project faces a legal hurdle after the Supreme Court dismissed its mining lease application.

EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.

Sprintex has locked in A$30 million in distribution agreements across the UK, Turkiye, and India, while advancing its innovative G25 Jet Blower launch, signaling a strong growth trajectory in energy-efficient technologies.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Winsome Resources has forged strategic partnerships to integrate carbon dioxide removal technologies with lithium production at its Renard Operation, aiming to generate verified carbon credits and set a new benchmark in sustainable mining.

Lotus Resources has locked in US$38.5 million in financing to support the restart and ramp-up of its Kayelekera uranium project in Malawi, targeting positive cash flow by Q3 2025.

Telix Pharmaceuticals has finalized its acquisition of RLS (USA) Inc., significantly expanding its radiopharmaceutical footprint across the United States with a network of over 30 radiopharmacies.